Cytokines and allergic disorders: Revisited study

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 3, 2004, Pages 233-235

  Frydas, Stavros ^a   Karagouni, E ^b   Hatzistilianou, M ^a   Kempuraj, D ^c   Comani, S ^d   Petrarca, C ^d   Iezzi, T ^d   Verna, N ^e   Conti, P ^d   Castellani, M L ^d  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CHIETI   (Italy)

^e University of Chieti ^*

Author keywords

Allergy; Cytokines; Immunotherapy; Mast cell; Th cell

Indexed keywords

ALLERGEN; BETA CHEMOKINE; CD4 ANTIGEN; CD45 ANTIGEN; CELL RECEPTOR; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CYTOKINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HISTAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTEGRIN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOCYTE ANTIGEN; VERY LATE ACTIVATION ANTIGEN 4;

ALLERGIC DISEASE; ALLERGIC REACTION; ANTIBODY PRODUCTION; ASTHMA; ATOPIC DERMATITIS; ATOPY; B LYMPHOCYTE; BASOPHIL; BRONCHUS HYPERREACTIVITY; CELLULAR IMMUNITY; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DOWN REGULATION; EDITORIAL; EFFECTOR CELL; EPIDERMIS CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOTHERAPY; INFLAMMATION; MACROPHAGE; MAST CELL; MAST CELL DEGRANULATION; MEMORY CELL; NATURAL KILLER CELL; NERVE ENDING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; SENSORY NERVE; SKIN CELL; SKIN INFLAMMATION; SKIN SENSITIZATION; STRESS; SYMPATHETIC NERVE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 8344234201     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700302     Document Type: Editorial

References (27)

1. Moseley T.A., D.R. Haudenschild, L. Rose and A.H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155.
2. Arena A., B. Enzo, G. Enrico, B. Marco and R. Graziella. 2003. Specific immunotherapy of allergic diseases: a three years perspective observational study. Int. J. Immunopathol. Pharmacol. 16:277.
3. v mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 15:249.
4. Mastrangelo G., C. Veller Fornasa, S. Pavanello, G. Marcer, M. Lazzaro, G. Milan, E. Fadda, U. Fedeli and E. Clonfero. 2003. Polyaromatic hydrocarbons administered in humans by dermal route increase total IgE. Int. J. Immunopathol. Pharmacol. 16:145.
5. Madonini E., F. Agostinis, R. Barra, A. Berra, D. Donadio, A. Pappacoda, E. Stefani and E. Tierno. 2003. Long-term and preventive effects of sublingual allergen-specific immunotherapy: a retrospective, multicentric study. Int. J. Immunopathol. Pharmacol. 16:73.
6. Chiappini E., M. Peruzzi, L. Galli, G. Calabri and M. de Martine. 2002. Dose-related IL-6 overproduction by phenobarbital-incubated peripheral blood mononuclear cells in a child with anticonvulsant hypersensitivity syndrome. Int. J. Immunopathol. Pharmacol. 15:239.
7. Vecchiet J., M. Dalessandro, F. Travasi, K. Falasca, A. Di Iorio, C. Schiavone, P. Zingariello, E. Di Ilio and E. Pizzigallo. 2003. Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int. J. Immunopathol. Pharmacol. 16:157.
8. Kasahara S., H. Wage and E.L. Cooper. 2002. Dissociation of innate and adaptive immunity by UVB irradiation. Int. J. Immunopathol. Pharmacol. 15:1.
9. Alexandrakis M.G., D.S. Kyriakou, D. Seretakis, W. Boucher, R. Letourneau, D. Kempuraj and T.C. Theoharides. 2003. Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1). Int. J. Immunopathol. Pharmacol. 16:43.
10. Kempuraj D., S. Frydas, K. Kandere, B. Madhappan, R. Letourneau, S. Christodoulou, W. Boucher, G. Riccioni, P. Conti and T.C. Theoharides. 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16:95.
11. Hurst S.D., T. Muchamuel, D.M. German, J.M. Gilbert, T. Clifford, S. Kwan, S. Menon, B. Seymour, C. Jackson, T.T. Kung, JK. Brieland, S.M. Zurawski, RW. Chapman, G. Zurawski and R.L. Coffman. 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169:443.
12. Aarvak T., M. Chabaud, P. Miossec and J.B. Natvig. 1999. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 162:1246.
13. Albanesi C., C. Scarponi, A. Cavani, M. Federici, F. Nasorri and G. Girolomoni. 2000. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol. 115:81.
14. Verna N., E. Cavallucci, F. Di Stefano, S. Ramondo, F. Paolini, R. Caruso, M. Grana, M. Mariano, C. Schiavone, R. Paganelli and M. Di Gioacchino. 2002. Cyclosporin-A in allergic diseases. Int. J. Immunopathol. Pharmacol. 15 (S):29.
15. Starnes T., H.E. Broxmeyer, M.J. Robertson and R. Hromas. 2002. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169:642.
16. Yoshino S., H. Hayashi, S. Taneda, H. Takano, M. Sagai and Y. Mori. 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 15:13.
17. Arena A., B. Enzo, G. Enrico, B. Marco and R. Graziella. 2003. Specific immunotherapy of allergic diseases: a three years perspective observational study. Int. J. Immunopathol. Pharmacol. 16:277.
18. K. Peris, M.C. Fargnoli, C. Mordenti, M. Sole Chimenti and S. Chimenti. 2002. Cyclosporin-A for treatment of psoriasis. Int. J. Immunopathol. Pharmacol. 15 (S):35.
19. Demidova T.N. and M.R. Hamblin. 2004. Targeted photodynamic therapy to inflammatory cells and pathogens. Int. J. Immunopathol. Pharmacol. 17:117.
20. Appert-Collin A., F.H.T. Duong, P. Passilly-Degrace, J.-P. Gies, J.-M. Warter and P. Poindron. 2004. Quantification of neurotrophin mRNA expression in PMN mouse: modulation by Xaliproden. Int. J. Immunopathol. Pharmacol. 17:157.
21. Pannellini T., M. Iezzi, E. Di Carlo, E. Eleuterio, A. Coletti, A. Modesti, S. Rosini, M. Neri and P. Musiani. 2004. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int. J. Immunopathol. Pharmacol. 17:171.
22. Bellussi L., F. Marcucci, L.G. Sensi, G.C. Passali, M. Lauriello, P.M. Passali, A.L. Giannuzzi and D. Passali. 2004. Do tryptase, ECP and specific IgE measurement by nasal incubation increase the specific nasal provocation test sensitivity? Int. J. Immunopathol. Pharmacol. 17:201.
23. Marchisio M., P.M. Grimley, A. Di Baldassarre, E. Santavenere and S. Miscia. 2004. Novel shift of Jak/Stat signaling characterizes the protective effects of aurintricarboxylic acid (ATA) from tumor necrosis factor-α toxicity in human B lymphocytes. Int. J. Immunopathol. Pharmacol. 17:5.
24. 4 counteracts interleukin-1β and transforming growth factor-β2 synergistic pro-inflammatory activation of human fibroblast-like synoviocytes. Int. J. Immunopathol. Pharmacol. 17:15.
25. Battistoni A., M. Ajello, S. Ammendola, F. Superti, G. Rotilio and P. Valenti. 2004. Involvement of reactive oxygen species in bacterial killing within epithelial cells. Int. J. Immunopathol. Pharmacol. 17:71.
26. Kempuraj D., S. Frydas, P. Conti, K. Kandere, W. Boucher, R. Letourneau, B. Madhappan, S.H. Huang, S. Koreaki, S. Christodoulou and T.C. Theoharides. 2003. Interleukin-25: a new IL-17 family member with growth factor/inflammatory action. Int. J. Immunopathol. Pharmacol. 16:185.
27. Trubiani O., E. Salvolini, R. Staffolani, R. Di Primio and L. Mazzanti. 2003. DMSO modifies structural and functional properties of RPMI-8402 cells by promoting programmed cell death. Int. J. Immunopathol. Pharmacol. 16:253